• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者利尿剂抵抗的病理生理学和治疗。

The pathophysiology and management of diuretic resistance in patients with heart failure.

机构信息

Department of cardiology, University of Oklahoma Health Sciences Center, Oklahoma, United States.

Department of cardiology, INTEGRIS Baptist Medical Center, Oklahoma, United States.

出版信息

Hosp Pract (1995). 2022 Apr;50(2):93-101. doi: 10.1080/21548331.2021.1893065. Epub 2021 Apr 12.

DOI:10.1080/21548331.2021.1893065
PMID:33596757
Abstract

OBJECTIVES

The objectives of the study are to investigate the causes of diuretic resistance in patients with advanced congestive heart failure (CHF), since diuretics are the cornerstone of treatment of these patients. Several studies have shown that diuretic resistance in patients with advanced CHF is common, ranging from 25% to 50% in hospitalized patients.

METHODS

In order to get a current perspective as to the magnitude of diuretic resistance in such patients, a focused Medline search of the English language literature was conducted between 2015 and 2020 using the search terms, CHF, diuretics, treatment, resistance, frequency, and 30 papers with pertinent information were selected.

RESULTS

The analysis of data from the selected papers demonstrated that diuretic resistance is common in hospitalized patients with advanced CHF and frequently associated with renal failure, which is secondary to CHF.

CONCLUSIONS

Diuretic resistance appears to be common in patients with advanced CHF and it is mostly due to decreased cardiac output, low blood pressure, decreased glomerular filtration rate, decreased filtration of sodium, and increased tubular reabsorption of sodium. Diuretic resistance in such patients can be overcome with the combination of loop diuretics with thiazide and thiazide-like diuretics, aldosterone antagonists, as well as other agents. The data from these studies in combination with collateral literature will be discussed in this review.

摘要

目的

本研究旨在探讨晚期充血性心力衰竭(CHF)患者利尿剂抵抗的原因,因为利尿剂是这些患者治疗的基石。几项研究表明,晚期 CHF 患者的利尿剂抵抗很常见,住院患者的比例为 25%至 50%。

方法

为了了解此类患者利尿剂抵抗的严重程度,我们在 2015 年至 2020 年间使用 CHF、利尿剂、治疗、抵抗、频率等英文术语对英文文献进行了重点 Medline 搜索,并选择了 30 篇具有相关信息的论文。

结果

对所选论文数据的分析表明,晚期 CHF 住院患者中利尿剂抵抗很常见,常伴有心力衰竭引起的肾衰竭。

结论

利尿剂抵抗在晚期 CHF 患者中似乎很常见,主要是由于心输出量降低、血压降低、肾小球滤过率降低、钠滤过减少和钠重吸收增加所致。联合使用袢利尿剂与噻嗪类和噻嗪样利尿剂、醛固酮拮抗剂以及其他药物可以克服此类患者的利尿剂抵抗。我们将结合相关文献对这些研究数据进行讨论。

相似文献

1
The pathophysiology and management of diuretic resistance in patients with heart failure.心力衰竭患者利尿剂抵抗的病理生理学和治疗。
Hosp Pract (1995). 2022 Apr;50(2):93-101. doi: 10.1080/21548331.2021.1893065. Epub 2021 Apr 12.
2
[Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].[醛固酮受体阻断在慢性心力衰竭患者利尿治疗中的价值]
Herz. 2002 Mar;27(2):135-49. doi: 10.1007/s00059-002-2352-0.
3
Combination diuretic therapy in severe congestive heart failure.重度充血性心力衰竭的联合利尿剂治疗
Drugs. 1998 Feb;55(2):165-72. doi: 10.2165/00003495-199855020-00001.
4
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中,静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标,尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
5
Diuretics in renal failure.肾衰竭中的利尿剂
Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):32-8. doi: 10.1159/000057416.
6
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.血管紧张素II AT1受体拮抗作用可预防急性利尿治疗对人类心力衰竭患者肾脏的有害作用。
Am J Physiol Renal Physiol. 2003 May;284(5):F1115-9. doi: 10.1152/ajprenal.00337.2002.
7
[Diuretic therapy in acute heart failure].[急性心力衰竭的利尿治疗]
Med Clin (Barc). 2014 Mar;142 Suppl 1:36-41. doi: 10.1016/S0025-7753(14)70081-8.
8
Thiazides and loop-diuretics therapeutic aspects.噻嗪类利尿剂和袢利尿剂的治疗作用
Acta Med Scand Suppl. 1986;707:75-8. doi: 10.1111/j.0954-6820.1986.tb18119.x.
9
Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.袢利尿剂与噻嗪类利尿剂联合应用于失代偿性心力衰竭患者的安全性和有效性(CLOROTIC)试验的原理与设计:一项双盲、随机、安慰剂对照研究,以确定联合利尿剂治疗(袢利尿剂与噻嗪类利尿剂联合)对失代偿性心力衰竭患者的疗效。
J Card Fail. 2016 Jul;22(7):529-36. doi: 10.1016/j.cardfail.2015.11.003. Epub 2015 Nov 11.
10
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.泼尼松对利尿剂抵抗难治的心力衰竭患者有强效利尿作用。
Can J Cardiol. 2007 Sep;23(11):865-8. doi: 10.1016/s0828-282x(07)70840-1.